SHANDONG BOAN BIOTECH.H 1 (UJ9) — Working Capital to Net Assets Ratio
SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Working Capital to Net Assets ratio of 41.9% as of December 2025. Working capital of €1.15 Billion (current assets of €2.01 Billion minus current liabilities of €864.65 Million) is measured against net assets of €2.74 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See SHANDONG BOAN BIOTECH.H 1 (UJ9) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SHANDONG BOAN BIOTECH.H 1 Working Capital to Net Assets (2021–2025)
This chart shows how SHANDONG BOAN BIOTECH.H 1's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 41.9%, reflecting working capital of €1.15 Billion against net assets of €2.74 Billion EUR. For the complete balance sheet picture, see SHANDONG BOAN BIOTECH.H 1 total assets.
Annual Working Capital to Net Assets for SHANDONG BOAN BIOTECH.H 1 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for SHANDONG BOAN BIOTECH.H 1 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check SHANDONG BOAN BIOTECH.H 1 liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 41.9% | €1.15 Billion | €2.74 Billion | €2.01 Billion | €864.65 Million | ▲ +23.2 pp |
| 2024 | 18.7% | €307.60 Million | €1.64 Billion | €956.28 Million | €648.68 Million | ▲ +14.2 pp |
| 2023 | 4.5% | €59.66 Million | €1.32 Billion | €713.01 Million | €653.35 Million | ▼ -21.9 pp |
| 2022 | 26.4% | €375.00 Million | €1.42 Billion | €846.67 Million | €471.67 Million | ▼ -17.3 pp |
| 2021 | 43.8% | €679.37 Million | €1.55 Billion | €939.85 Million | €260.48 Million | — |